EVALUATING POTENTIAL IATROGENIC SUICIDE RISK IN TRAUMA-FOCUSED GROUP COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF PTSD IN ACTIVE DUTY MILITARY PERSONNEL
EVALUATING POTENTIAL IATROGENIC SUICIDE RISK IN TRAUMA-FOCUSED GROUP COGNITIVE BEHAVIORAL THERAPY FOR THE TREATMENT OF PTSD IN ACTIVE DUTY MILITARY PERSONNEL
复制标题
DOI：
10.1002/da.22456
复制
发表时间：
2016-06-01
影响因子：
7.4
通讯作者：
Resick, Patricia A.
中科院分区：
文献类型：
--
作者：
Bryan, Craig J.;Clemans, Tracy A.;Resick, Patricia A.
目的：在被诊断为创伤后应激障碍（PTSD）的现役美国陆军人员样本中，确定团体认知加工治疗-仅认知版本（CPT-C）是否与医源性自杀风险相关。考虑的可能医源性影响包括接受CPT-C组的士兵中自杀意念的发生率和严重程度、既存自杀意念的恶化、新发自杀意念的发生率和自杀企图的发生率。与以现在为中心的治疗（PCT）组进行比较，以了解结果。方法：108名（100名男性，8名女性）诊断为PTSD的士兵被随机分为CPT-C组或PCT组。PTSD诊断通过结构化临床医生访谈确认。在治疗前、治疗期间每周、治疗后2周、6个月和12个月评估自杀意念、抑郁严重程度和PTSD严重程度。结果：两种治疗组的自杀意念发生率均显著降低。在治疗前有自杀意念的士兵中，自杀意念的严重程度在两种治疗中均显著降低，并在治疗后维持长达12个月。在两种治疗中，既存自杀意念的加重均不常见。新发自杀意念在两种治疗中均罕见且相似（
Objective: To determine whether group cognitive processing therapy-cognitive only version (CPT-C) is associated with iatrogenic suicide risk in a sample of active duty US Army personnel diagnosed with posttraumatic stress disorder (PTSD). Possible iatrogenic effects considered include the incidence and severity of suicide ideation, worsening of preexisting suicide ideation, incidence of new-onset suicide ideation, and incidence of suicide attempts among soldiers receiving group CPT-C. Comparison with group present-centered therapy (PCT) was made to contextualize findings. Method: One hundred eight soldiers (100 men, eight women) diagnosed with PTSD were randomized to receive either group CPT-C or group PCT. PTSD diagnosis was confirmed via structured clinician interview. Suicide ideation, depression severity, and PTSD severity were assessed at pretreatment, weekly during treatment, and 2 weeks, 6 months, and 12 months posttreatment. Results: Rates of suicide ideation significantly decreased across both treatments. Among soldiers with pretreatment suicide ideation, severity of suicide ideation significantly decreased across both treatments and was maintained for up to 12 months posttreatment. Exacerbation of preexisting suicide ideation was uncommon in both treatments. New-onset suicide ideation was rare and similar across both treatments (